Testimonials

It is very nice to visit Lambda facility and thanks to warm welcome provided by all the teams. I can easily say one of the best CRO I ever visited. People here are wonderful and doing great job

Reputed Client of Israel

Awesome hospitality & fantastic office. All the best!

Reputed Client of Japan

Excellent hospitality and cooperation received throughout the audit. People are knowledgeable and extremely transparent. Looking for long time relation

Reputed Client of Asia

Facility is too good to conduct the BABE studies and adherence to protocol and quality assurance in conducting studies are meeting sponsor expectations and requirements.

Reputed Client of India

Facility is good, people r trained well and know the subject on which they r working. All the best.

Reputed Client of USA

Highly innovative and advanced research centre that possess bright future for the development of the country.

Reputed International Government Body

It is one of the best facility in India for BA/BE

Reputed Regulatory Authority

Lambda is a very professional CRO. All the staff here are experienced and very knowledgeable. I'm grateful for their accommodations and hospitality. The future, if we want to carry out BE study, we will ask Lambda help again.

Reputed Client of Europe

It was a really pleasant meeting with the PV department, and I am looking forward to the next visit.

Reputed Client of Europe

Amazing and best CRO I ever seen

Reputed Client of China

Blog

Blog/Phase II-IV

Home / Blog

Advancing Pediatric Clinical Trials: Overcoming Challenges i...

09 Oct 2023

Pegfilgrastim, a drug with proven efficacy in adults, was investigated in pediatric patients. Although studies in adults demonstrated similar efficacy...

Read More



Overcoming Challenges in a Multicenter Oncology Clinical Tri...

12 Aug 2023

The study aimed to characterize the pharmacokinetic profile and to assess the bioequivalence of Liposomal doxorubicin (TEST) in comparison to RLD (Cae...

Read More



Accelerating Patient Recruitment: Topical Tacrolimus for Ato...

07 Jul 2023

Successful Enrolment of 783 Patients across India, in Two Phase III Studies on Topical Tacrolimus for Atopic Dermatitis in Just 5 Months......

Read More



Address the Unmet Needs in Paediatric Drug Development with ...

06 Apr 2023

Address the Unmet Needs in Paediatric Drug Development with Lambda. Partner with Lambda for customized solutions at a project, program and com...

Read More



Critical Challenges to the Management of Imaging in Clinical...

06 Apr 2023

Clinical trials enable the development and access of new drugs to patients. Imaging is considered a valuable tool which forms the basis of robust res...

Read More



Breakthrough Therapy Designation from U.S. Food and Drug Adm...

31 Aug 2018

Major depressive disorder (MDD) affects approximately 16 million people in the U.S. and 121 million people worldwide. As per the report on global burd...

Read More



BRCA1 Gene Mutation: Women at Increased Risk of Aggressive U...

07 Aug 2018

BRCA1 and BRCA2 genes regulate the prosecution of tumor suppressor proteins in humans to repair damaged DNA. When one of these genes gets mutated, cel...

Read More



HER2 Positive Breast Cancer: New Treatment Horizon

05 May 2018

Introduction Breast cancer (BC) is one of the major cancers, second most common, in females worldwide. 1.7 billion Breast cancer Cases were reported i...

Read More



Looking for a Globally Proven Research Partner?

Contact Us